Cognizant Technology Solutions Corporation (CTSH)
Quantitative Summary
DeterministicAt 13.3x earnings — a 80% discount to the sector average of 65.0x — CTSH is in the lower valuation range. Financial health metrics are strong: Piotroski 7/9, Altman Z 5.9 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Cognizant Technology Solutions Corporation reveal a capital allocation profile that starkly contrasts with its sector peers. While the company generates value through an ROIC-WACC spread indicative of efficient operations, supported by a robust Piotroski F-Score of 7/9 and a clean Beneish M-Score of -2.52 suggesting low earnings manipulation risk, it relies heavily on financial leverage to drive returns rather than operational intensity or pricing power. The DuPont decomposition highlights this structural reliance: an equity multiplier of 1.38x amplifies the modest asset turnover of 1.02x and net margin of 10.6% into a total ROE of 14.8%. This leverage-dependent growth model, coupled with revenue expansion limited to 7.0% year-over-year, presents a distinct risk/reward asymmetry compared to high-growth peers that typically utilize organic volume drivers.
Valuation metrics indicate the market is pricing in significantly lower multiple compression relative to the broader technology sector average of 57.8x, resulting in a current P/E of only 13.3x. This substantial discount suggests investors are not anticipating rapid acceleration in profitability or margin expansion at this time, despite the company's solid fundamentals and low distress risk as indicated by its financial scores. A DCF analysis implies an intrinsic fair value of $90, which provides a quantitative anchor for assessing whether current market pricing adequately compensates for the growth constraints inherent in the business model. The divergence between the conservative valuation multiples and the defensive quality metrics creates a scenario where downside protection may be structurally embedded within the price, though upside remains tethered to the ability to convert this low multiple into higher earnings per share over time.
Recent insider activity adds another layer of nuance to the investment thesis, with net selling totaling $1,172,948 over the past 90 days. While not necessarily indicative of a fundamental deterioration given the company's high F-Score and negative M-Score, this flow suggests management may view current valuations or future growth prospects as less attractive than historical levels. The combination of insider disposition, moderate revenue growth, and leverage-driven ROE implies that while the stock offers defensive characteristics relative to its sector, capital appreciation will likely depend on a re-rating driven by improved operational efficiency rather than multiple expansion.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8.8% | 10.8% | 12.8% |
|---|---|---|---|
| 2% | $106 | $82 | $67 |
| 3% | $121 | $90 | $72 |
| 4% | $141 | $100 | $77 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.8%, terminal growth 3%. Fair value $90 (+0.0%). Not investment advice.
Valuation Context
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like ONEV or XSW, the fund manager is mechanically forced to buy or sell CTSH shares regardless of Cognizant Technology Solutions Corporation's individual fundamentals. We estimate $5.0B of passive capital is structurally linked to CTSH through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Cognizant Technology Solutions Corporation to visualize passive redemption contagion across ETFs and collateral stocks.
If Cognizant Technology Solutions Corporation (CTSH) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Western Digital Corp. (WDC) as the most exposed collateral stock, sharing 2 ETFs with CTSH. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 30 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CTSH Ownership Dynamics
ETFs with Highest CTSH Exposure
Float lock-up computed from 30 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
CTSH Capital Efficiency
How efficiently does Cognizant Technology Solutions Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Cognizant Technology Solutions Corporation converts 64% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 5.5% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 13,551 | $47.73 | $646,789.23 |
| 2026-05-07 | 1,302 | $51.33 | $66,831.66 |
| 2026-05-06 | 42,044 | $51.87 | $2.2M |
| 2026-05-01 | 72,923 | $52.90 | $3.9M |
| 2026-04-28 | 9 | $54.63 | $491.67 |
| 2026-04-23 | 3,706 | $58.81 | $217,949.86 |
| 2026-04-20 | 8 | $61.30 | $490.4 |
| 2026-04-17 | 193 | $60.53 | $11,682.29 |
| 2026-04-16 | 4 | $60.39 | $241.56 |
| 2026-04-15 | 1,028 | $60.04 | $61,721.12 |
| 2026-04-01 | 14 | $61.35 | $858.9 |
| 2026-03-30 | 16 | $59.73 | $955.68 |
| 2026-03-25 | 48 | $60.24 | $2,891.52 |
| 2026-03-24 | 497 | $61.94 | $30,784.18 |
| 2026-03-23 | 172,100 | $62.07 | $10.7M |
| 2026-03-17 | 2 | $61.05 | $122.1 |
| 2026-03-09 | 1,618 | $66.26 | $107,208.68 |
| 2026-03-06 | 826 | $65.78 | $54,334.28 |
| 2026-03-05 | 826 | $65.12 | $53,789.12 |
| 2026-03-02 | 27,837 | $64.43 | $1.8M |
| 2026-02-26 | 16 | $61.33 | $981.28 |
| 2026-02-24 | 3,122 | $61.13 | $190,847.86 |
| 2026-02-18 | 66 | $65.18 | $4,301.88 |
| 2026-02-12 | 43 | $70.91 | $3,049.13 |
| 2026-02-10 | 5 | $74.60 | $373 |
| 2026-02-06 | 4 | $76.84 | $307.36 |
| 2026-02-04 | 144,908 | $74.50 | $10.8M |
| 2026-01-30 | 107,097 | $82.45 | $8.8M |
| 2026-01-29 | 14 | $83.30 | $1,166.2 |
| 2026-01-28 | 7,136 | $84.65 | $604,062.4 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CTSH to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.